Neuropeptide Y receptor 1 (NPY-Y1) expression in human heart failure and heart transplantation.

[1]  G. Barsh,et al.  Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Katsuya,et al.  Angiotensin II receptor subtypes in falling and non-falling human hearts: Analysis of gene expression , 1996 .

[3]  Herbert Herzog,et al.  Multiple Promoters Regulate Tissue-specific Expression of the Human NPY-Y1 Receptor Gene (*) , 1995, The Journal of Biological Chemistry.

[4]  K. Kodukula,et al.  Cloning and Functional Expression of a cDNA Encoding a Human Type 2 Neuropeptide Y Receptor (*) , 1995, The Journal of Biological Chemistry.

[5]  J. Cohn.  Critical review of heart failure: The role of left ventricular remodeling in the therapeutic response–Cohn: Remodeling in heart failure , 1995, Clinical cardiology.

[6]  J. Port,et al.  776-1 Selective Down-regulation of Angiotensin II AT1 Receptors in Failing Human Heart: Relationship to β1-Receptor Down-regulation , 1995 .

[7]  G. Perdew,et al.  Regulation of Gene Expression , 2008, Goodman's Medical Cell Biology.

[8]  X. J. Zhou,et al.  Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes. , 1994, The American journal of physiology.

[9]  J. Cheng,et al.  The human apolipoprotein(a)/plasminogen gene cluster contains a novel homologue transcribed in liver. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  C. Burlet,et al.  In vivo monitoring of myocardial interstitial neuropeptide tyrosine release following brain death. , 1993, Transplantation proceedings.

[11]  J. Saffitz,et al.  Heterogeneous Transmural Distribution of Beta‐Adrenergic Receptor Subtpes in Failing Human Hearts , 1993, Circulation.

[12]  B. McDermott,et al.  Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms. , 1993, Cardiovascular research.

[13]  P. Mantyh,et al.  Neuropeptide Y/peptide YY receptor binding sites in the heart: Localization and pharmacological characterization , 1993, Neuroscience.

[14]  C. Wahlestedt,et al.  Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells , 1993, Peptides.

[15]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[16]  J. Shine,et al.  Cloned human neuropeptide Y receptor couples to two different second messenger systems. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Larhammar,et al.  Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. , 1992, The Journal of biological chemistry.

[18]  L. Mestroni,et al.  Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. , 1992, The Journal of clinical investigation.

[19]  C. Wahlestedt,et al.  Characterization of vascular neuropeptide Y receptors , 1992, British journal of pharmacology.

[20]  J. Port,et al.  Myocardial Catecholamine and Neuropeptide Y Depletion in Failing Ventricles of Patients With Idiopathic Dilated Cardiomyopathy: Correlation With β‐Adrenergic Receptor Downregulation , 1992, Circulation.

[21]  D. Reis,et al.  Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY. , 1992, Life sciences.

[22]  K. Mizuno,et al.  Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats. , 1992, Life sciences.

[23]  R. Wilson,et al.  Evidence for Structural Sympathetic Reinnervation After Orthotopic Cardiac Transplantation in Humans , 1991, Circulation.

[24]  E. Fleck,et al.  Myocardial catecholamine content after heart transplantation. , 1990, Circulation.

[25]  M. Bristow,et al.  The surgically denervated, transplanted human heart. , 1990, Circulation.

[26]  G. Burnstock,et al.  Sympathetic and nonsympathetic neuropeptide Y-containing nerves in the rat myocardium and coronary arteries. , 1990, Circulation research.

[27]  H. Zimmer,et al.  Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy. , 1989, Circulation research.

[28]  G. Grupp,et al.  Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles. , 1989, The American journal of physiology.

[29]  J. Gordon,et al.  Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts. , 1989, Circulation.

[30]  M. Bristow,et al.  Beta-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin. , 1989, Circulation.

[31]  H. Motulsky,et al.  Elevation of plasma neuropeptide Y levels in congestive heart failure. , 1989, The American journal of medicine.

[32]  R. Bjørnerheim,et al.  Increased beta-adrenoceptor-coupled adenylate cyclase response in transplanted human hearts. , 1987, Scandinavian journal of clinical and laboratory investigation.

[33]  C. Wahlestedt,et al.  Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. , 1985, The Journal of pharmacology and experimental therapeutics.

[34]  S. Vatner,et al.  Mechanisms of Supersensitivity to Sympathomimetic Amines in the Chronically Denervated Heart of the Conscious Dog , 1985, Circulation research.

[35]  J. Polak,et al.  High concentrations of a novel peptide, neuropeptide Y, in the innervation of mouse and rat heart. , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  T. Hökfelt,et al.  Coexistence of peptides and classical neurotransmitters , 1983, Trends in Neurosciences.